02315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 60.60
−5.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 61.28x
- P/E 2027E
- 38.55x
- P/E 2028E
- 25.07x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 43.60x
- PEG TTM
- —
- Price / book
- 8.58x
- Price / sales
- 7.22x
- Price / cash flow
- 26.10x
Enterprise value
- Enterprise value
- HKD 24.1B
- EV / sales
- 7.17x
- EV / EBITDA
- 21.42x
- EV / EBIT
- 29.51x
- Market cap
- HKD 24.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026